Relevance of Free tPA Assay Following Venous Occlusion in Patients with Venous Thromboembolic Disease

M C Alessi; I Juhan-Vague; J Valadier; C Philip Joet; P Holvoet; D Collen

doi:10.1055/s-0038-1642794

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1988; 59(02): 346-347
DOI: 10.1055/s-0038-1642794

letter to editor

Schattauer GmbH Stuttgart

Relevance of Free tPA Assay Following Venous Occlusion in Patients with Venous Thromboembolic Disease

Authors

M C Alessi

¹Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
I Juhan-Vague

¹Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
J Valadier

¹Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
C Philip Joet

¹Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
P Holvoet

²Center for Thrombosis and Vascular Research, Leuven, Belgium
D Collen

¹Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium

Abstract

als PDF herunterladen

PDF (84 kb)

Referenzen

References
1 Brommer EJ P, Verheijen JH, Chang GT G, Rijken DC. Masking offibrinolytic response to stimulation by an inhibitor of tissue-typeplasminogen activator in plasma. Thromb Haemostas 1984; 52: 154-156
2 Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms inpatients with venous thrombosis and defective fibrinolysis: low concen-tration of plasminogen activator and increased concentration of plas-minogen activator inhibitor. Brit Med J 1985; 290: 1453-1455
3 Stalder M, Hauert Y, Kruithof EK O, Bachmann F. Release ofvascular plasminogen activator (t-PA) after venous stasis: Elec-trophoretic zymographic analysis of free and complexed tPA. Brit JHaematol 1985; 61: 169-176
4 Juhan-Vque I, Valadier J, Aiessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradirnigni A, Colien D. Deficient tPA release and elevated PA inhibitor levels in patients with spontaneous or recurrcnr deep venous thrombosis. Thromb Haernostai 1987; 57: 67-72
5 Holvoet P, Boes J, Coilen D. Measurenient of free, one-chain tissue type piasniinogen activator in human plasma with an enzyme-linked immunosorbent assay based on an active site speciflc murine monoclonal antibody. Blood 1987; 69: 281-9
6 Kluft C, Brakman P, Veldhuyzen-Stolk EC. Screening of fihrinolytic activit) in plasma euplobuiin fraction on the fibrin plate. In Progress in Chemical Fihrinolysis and Thrombosis. Davidson IF, Samama MM, Desnoyers PC. (Eds). vol II pp 57-65 Raven Press; New York: 1976
7 Verheijen JH, Chang GT G, Kluft C. Evidence for the occurrence of a fast acting inhibitor for tissue-type plasrninogen activator in human plasma. Thromb Haemostas 1984; 51: 392-5
8 Gaffncy PJ, Curtis AD. A coiiaborativc study of a proposed international standard for tissue plasminogen activator (tPA). Thromb Haernostas 1985; 53: 134-6
9 Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (tPA) with an enzyne-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA. Thromb Haemostas 1985; 54: 684-7